Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results for the quarter ended31st March 2025
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India has published its Q4 FY25 unaudited financial results in Business Standard and Sakal newspapers on 3 May 2025, after Board approval on 2 May 2025. Total income from operations for the quarter stood at Rs 1,778 million, up marginally from Rs 1,757 million in Q4 FY24. Net profit after tax rose about 12.9% YoY to Rs 500 million (from Rs 443 million), with EPS of Rs 21.69 versus Rs 19.25 in the year-ago quarter. Sequentially, both revenue and profit declined compared to Q3 FY25 (revenue: Rs 2,246M, PAT: Rs 627M). For full year FY24 (audited), total income was Rs 7,375M with PAT of Rs 1,810M and EPS of Rs 78.59.
The filing is a routine regulatory newspaper publication of quarterly results, not new information for the market. The modest revenue growth but stronger profit and EPS growth in Q4 FY25 indicate healthy margin expansion, which is mildly positive for shareholders.